Token Launch definition

Token Launch means the bona fide issuance of the Tokens to Purchaser that is compliant with the ERC-20 standard (or any other standard that the Company may elect in its sole discretion).
Sample 1Sample 2Sample 3
Token Launch means a bona fide transaction or series of transactions, pursuant to which the Company will sell the Tokens to the general public in a publicized product launch.
Sample 1
Token Launch means a transaction or series of transactions, pursuant to which the Company will sell the Tokens to the public in a public product launch.
Sample 1

Examples of Token Launch in a sentence

  • Token Launch is a very similar event to ICO, because it also deals with the public selling of tokens.

  • The Buyer understands that any Tokens involve risks, all of which the Buyer fully and completely assumes, including, but not limited to, the risk that (i) the technology associated with the Ecosystem will not function as intended; (ii) the Token Launch will not be completed; (iii) the Ecosystem will fail to attract sufficient interest from key stakeholders; and (iv) the Company and/or the Ecosystem may be subject to investigation and punitive actions from Governmental Authorities.

  • The past three years of Token Launch data can be seen below: Total Financing (USD)YoY GrowthToken Launch InstancesYoY Growth20175,600M849%435912%2016590M496%43514%201599M 7 Market participants have historically seen high returns.

  • In the worst-case scenario, Tokens could be rendered worthless.The Token Launch and the performance of the Company’s activities set out in this Whitepaper and the development roadmap may be interrupted, suspended or delayed due to force majeure circumstances.

  • For instance, Venture Capital and ICO or Crowdfunding and Token Launch.

  • If there is a Token Launch before the expiration or termination of this instrument, the Company will automatically issue to the Buyer a number of units of the Token equal to the Purchase Amount divided by the Discount Price.

  • Kuva ubwo, rubanda rwatangiye kumubona nk’umuntu usanzwe, aho kumubonamo ububasha bukomoka ku Mana.

  • Failure to follow the Token Launch instructions on the Website may limit, delay, or prevent a Participant from Exchange.

  • Sec- ondly, the project could consider Token Launch as an alternative to Counterparty proto- col.

  • Do not participate in this Token Launch if you are not familiar with or do not understand cryptocurrencies, cryptographic tokens, and blockchainbased software systems.


More Definitions of Token Launch

Token Launch means a bona fide issuance of Tokens to the general public in a publicized product launch and provided that the satisfaction of this clause shall be determined by the Company in its sole discretion.
Sample 1

Related to Token Launch

  • Launch means the intentional ignition of the first-stage motor(s) of the Launch Vehicle intended to place or try to place a Launch Vehicle (which may or may not include any Transfer Vehicle, Payload or crew) from Earth:

  • Commercial Launch means the initial First Commercial Sale of a Product in the Territory.

  • Launch Date has the meaning specified therefor in Section 2.02(b) of this Agreement.

  • Launch Vehicle means an object, or any part thereof, intended for launch, launched from Earth, or returning to Earth which carries Payloads or persons, or both.

  • FDA Approval means the approval, license, clearance or authorization of the FDA necessary for the marketing and sale of a product for human use in the United States.

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Marketing Authorization means all approvals, licenses, registrations or authorizations of any federal, state or local regulatory agency, department, bureau or other governmental entity, necessary for the manufacturing, use, storage, import, transport, marketing and sale of Licensed Products in a country or regulatory jurisdiction.

  • Regulatory Approval means any and all approvals (including MAA Approval, and Pricing and Reimbursement Approval, if applicable), licenses, registrations, permits, notifications and authorizations (or waivers) of any Regulatory Authority that are necessary for the manufacture, use, storage, import, transport, promotion, marketing, distribution, offer for sale, sale or other commercialization of a Product in any country or jurisdiction.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Licensed System means, collectively:

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Commercial Sale means the sale of Product (as indicated by shipment of Product) to an unaffiliated third-party of the Licensee, or of its sublicensee or distribution partner, such as a wholesaler, managed care organization, hospital or pharmacy and shall exclude (i) any transfer of Product by Licensee to its sublicensee, distribution partner or Affiliate and (ii) any distribution of Product for use in research, development, pre-clinical and clinical trials.

  • Final Product means a reasonably homogenous cannabis product in its final packaged form created using the same standard operating procedures and the same formulation.

  • Video programming means programming provided by, or generally considered comparable to programming provided by, a television broadcast station.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • XXXXX System means the XXXXX filing system of the Commission and the rules and regulations pertaining thereto promulgated by the Commission in Regulation S-T under the Securities Act and the Exchange Act, in each case as the same may be amended or succeeded from time to time (and without regard to format).

  • Marketing Authorization Application or “MAA” means an application for Regulatory Approval (but excluding Pricing Approval) in any particular jurisdiction other than the U.S.

  • Regulatory Approval Application means any application submitted to an appropriate Regulatory Authority seeking any Regulatory Approval.